Unbuzzd Wellness names Michael Zapolin as CEO ahead of planned stock listing

Quantum BioPharma Ltd. announced on September 24, 2026 that its licensee Unbuzzd Wellness Inc., the company behind the unbuzzd beverage marketed as an alcohol metabolism accelerant, appointed Michael Zapolin as CEO.¹ The company described the appointment as a pivotal milestone for the company.¹

Zapolin's responsibilities cover arranging financing and a stock exchange listing for Unbuzzd, followed by a nationwide commercial marketing and product rollout in the United States.¹

Richard Buzbuzian, who had served as Unbuzzd's CEO, is helping with the transition as the company works toward becoming publicly listed, with that process expected to take effect next quarter.¹

Quantum BioPharma described its own relationship to the product this way: Quantum invented UNBUZZD and spun out its OTC version to Unbuzzd Wellness Inc. (formerly Celly Nutrition Corp.), led by industry veterans.¹ As of the release date, Quantum retains ownership of 19.48% of Unbuzzd, as of June 30, 2026.¹ Financial terms include royalty payments of 7% of unbuzzd sales to Quantum until cumulative payments reach $250 million, after which the royalty rate drops to 3% in perpetuity.¹

The release also cited results from a clinical trial backing the product, noting that blood alcohol concentration dropped over 40 percent faster in most participants within 30 minutes of taking unbuzzd, compared with a control group.¹ The study also reported statistically significant reductions in hangover symptoms, including a 67 percent drop in headache severity at four hours after consumption, with effects continuing at eight hours.¹